XML 43 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders' Equity and Share-based Compensation (Tables)
9 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Restricted Stock Units Activity
Time-based Restricted Stock Units (TRSU)
The following table summarizes the Company's TRSU activities for the nine months ended March 31, 2022:
 Number of Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Contractual
Term (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 20211,053,524 $21.60 1.73$32,016,594 
Granted563,681 $46.10 
Vested(380,029)$20.01 
Forfeited(46,251)$23.14 
Nonvested at March 31, 20221,190,925 $33.64 1.92$65,084,051 
The following table summarizes the Company’s PRSUs activities for the nine months ended March 31, 2022:

 Number of Performance-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Contractual Term
(Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2021353,824 $22.69 1.74$10,752,711 
Granted194,000 $48.65 
Vested(151,199)$19.44 
Forfeited(1,000)$16.22 
Nonvested at March 31, 2022395,625 $36.68 2.11$21,620,906 
Summary of Stock Option Activities The following table summarizes the Company's stock option activities for the nine months ended March 31, 2022:
Weighted
WeightedAverage
AverageRemaining
Number ofExercise PriceContractual Aggregate
SharesPer ShareTerm (in years)Intrinsic Value
Outstanding at June 30, 2021487,875 $7.99 2.32$10,928,653 
Exercised(93,000)$9.24 
Outstanding at March 31, 2022394,875 $7.70 1.78$18,541,050 
Options vested and expected to vest394,875 $7.70 1.78$18,541,050 
Exercisable at March 31, 2022394,875 $7.70 1.78$18,541,050 
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions The assumptions used to estimate the fair values of common shares issued under the ESPP were as follows:
Nine Months End March 31,
2022
Volatility rate66.4%
Risk-free interest rate0.3%
Expected term1.3 years
Dividend yield0%
Share-based Compensation, Allocation of Recognized Period Costs
Share-based Compensation Expense
The total share-based compensation expense recognized in the Condensed Consolidated Statements of Income for the periods presented was as follows:
Three Months Ended March 31, Nine Months Ended March 31,
2022202120222021
(in thousands)(in thousands)
Cost of goods sold$1,282 $427 $3,560 $1,195 
Research and development1,814 1,316 4,769 3,639 
Selling, general and administrative5,177 2,082 13,125 5,091 
$8,273 $3,825 $21,454 $9,925